COMMUNIQUÉS West-GlobeNewswire

Intra-Cellular Therapies Announces Presentation of Lumateperone Long-term Open Label Safety Study at the 2019 Congress of the Schizophrenia International Research Society
09/04/2019
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
T2 Biosystems and Clinicians to Share Clinical Data in Integrated Symposium and Poster Presentations at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
09/04/2019
Data will highlight how direct-from-whole blood innovations—the T2Bacteria, T2Candida and T2Resistance panels—positively impact patients with bloodstream infections LEXINGTON, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- [...]
Inhibikase Therapeutics Announces Appointment of Elizabeth O’Farrell to its Board of Directors
09/04/2019
ATLANTA and BOSTON, April 09, 2019 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc., a pharmaceutical company developing protein kinase inhibitors for the treatment of neurological infections and neurodegenerative [...]
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
09/04/2019
Expands use of PhaseBio ELP biopolymer platform designed to support more convenient dosing of proteins and peptides MALVERN, Pa. and SAN DIEGO, April 09, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: [...]
Chembio Diagnostics Announces Approval of Zika, Dengue and Chikungunya Point-of-Care Multiplex Test by Brazil’s Health Regulatory Agency
09/04/2019
MEDFORD, N.Y., April 09, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced the approval of its DPP Zika/Dengue [...]
VBI Vaccines Announces Late-Breaking Poster Presentation at EASL 2019
09/04/2019
Poster presentation to highlight data from three previously-conducted clinical studies of Sci-B-Vac®, VBI’s prophylactic Hepatitis B vaccine In all three studies, seroprotection rates of more than 98% were achieved [...]
Cerner Announces Agreement with Starboard Value Regarding Board Refreshment, Operational Improvement Initiatives and Expanded Capital Return Program to Drive Next Phase of Profitable Growth and Value Creation
09/04/2019
Four New Directors to Be Immediately Appointed to the Board of Directors Commitment to Adjusted Operating Margin Targets for Q4 2019 and Q4 2020 of 20% and 22.5%, Respectively 1 Creation of Finance and Strategy [...]
Frank J. Quintero Joins BioSig Technologies Advisory Board
09/04/2019
Santa Monica, CA, April 09, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Tauriga Sciences, Inc. to Develop Airport Version of its CBD Infused Chewing Gum
09/04/2019
NEW YORK, NY, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
United Smart Cities and Cure Pharmaceutical Launch Global Healthcare Awareness Initiative
09/04/2019
LOS ANGELES, April 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced a global healthcare awareness initiative with United Smart Cities for [...]
Myriad Genetics Submits First Module of the Premarket Approval Application to FDA for the myChoice® HRD CDx Test
09/04/2019
myChoice HRD Is Intended to Identify Patients with Ovarian, Fallopian or Primary Peritoneal Cancer Who May Benefit from Treatment with Zejula SALT LAKE CITY, April 09, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. ( [...]
MediPharm Labs Announces OTC Ticker Symbol Change to “MEDIF”
09/04/2019
TORONTO, April 09, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
CureVac to Participate in Upcoming Investor Conferences
09/04/2019
TÜBINGEN, Germany and BOSTON, April 09, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced its participation in two upcoming [...]
HALO Labs: Building A Cannabis Concentrate & Oil Empire -- CFN Media
09/04/2019
SEATTLE, WA, April 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of [...]
Emerald Health Therapeutics to Present at Investment Conferences in April
09/04/2019
VANCOUVER, British Columbia, April 09, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), a licensed producer of cannabis products for medical and recreational purposes, [...]
Aleafia Health to Announce 2018 Financial Results
09/04/2019
TORONTO, April 09, 2019 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“ Aleafia Health ” or the “ Company ”) will announce its 2018 Financial Results on April 29, 2019 at 7:00 a.m. EDT. The [...]
New Study Deepens Research Into the Potential Cardiovascular Health Benefits of Supplementation with Nicotinamide Riboside (NR)
09/04/2019
Data published in the Journal of American College of Cardiology shows that this novel form of vitamin B3 helps maintain mitochondrial function in an animal model by stimulating a cellular repair pathway; preliminary [...]
Tetra Bio-Pharma Resumes its Phase 3 Clinical Trial Program
09/04/2019
The expansion to 20 clinical trial sites in Canada and the US will accelerate the SERENITY© study OTTAWA, April 09, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: [...]
BioAtla and BeiGene Form Worldwide Collaboration to Develop and Commercialize Novel Conditionally Active Biologic CTLA-4 Therapy
09/04/2019
Plan to pursue development as a monotherapy and in combination with BeiGene’s investigational anti-PD-1 antibody, tislelizumab SAN DIEGO and BEIJING, China and CAMBRIDGE, Mass., April 09, 2019 (GLOBE NEWSWIRE) -- [...]

Pages